Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with heart failure: Comparison with enalapril

被引：0
|
作者：
Abassi, ZA
Zeid, S
Yahia, A
Winaver, J
Hoffman, A
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Dept Physiol & Biophys, Haifa, Israel
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
omapatrilat; cardiac hypertrophy; renal function;
D O I：
10.1016/S0895-7061(03)00288-7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P123
引用
收藏
页码：84A / 84A
页数：1
相关论文
共 50 条
  • [31] Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure
    Lapointe, N
    Tsoporis, JN
    Parker, TG
    Blais, C
    Adam, A
    Rouleau, D
    Slaughter, G
    Clément, R
    Deschepper, CF
    Rouleau, JL
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 254 (1-2) : 235 - 245
  • [32] The vasopeptidase inhibitor, omapatrilat, has a favorable, pressure-independent effect on conduit vessel stiffness in patients with congestive heart failure
    Mitchell, GF
    Block, AJ
    Hartley, HL
    Tardif, JC
    Rouleau, JL
    Pfeffer, MA
    CIRCULATION, 1999, 100 (18) : 646 - 646
  • [33] Comparative effects of quinapril with enalapril in rats with heart failure
    Watanabe, K
    Ma, ML
    Wen, JA
    Tachikawa, H
    Kodama, M
    Aizawa, Y
    Yamaguchi, K
    Takahashid, T
    PHARMACOLOGY, 2004, 71 (03) : 157 - 161
  • [34] Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure
    Toshiyuki Maki
    Yoshihisa Nasa
    Kouichi Tanonaka
    Masaya Takahashi
    Satoshi Takeo
    Molecular and Cellular Biochemistry, 2003, 254 : 265 - 273
  • [35] Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure
    Troughton, RW
    Rademaker, MT
    Powell, JD
    Yandle, TG
    Espiner, EA
    Frampton, CM
    Nicholls, MG
    Richards, AM
    HYPERTENSION, 2000, 36 (04) : 523 - 530
  • [36] Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation
    Maki, T
    Nasa, Y
    Tanonaka, K
    Takahashi, M
    Takeo, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 97 - 105
  • [37] Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure
    Maki, T
    Nasa, Y
    Tanonaka, K
    Takahashi, M
    Takeo, S
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 254 (1-2) : 265 - 273
  • [38] Comparison of long-term dual vasopeptidase inhibition with omapatrilat to ACE inhibition with lisinopril on ventricular volumes in patients with heart failure
    Udelson, JE
    Antonopoulos, GV
    Proulx, G
    Sussez, BA
    Arnold, JM
    Kouz, S
    Mehta, SS
    Konstam, MA
    CIRCULATION, 2000, 102 (18) : 536 - +
  • [39] EFFECTS OF ENALAPRIL ON RENAL-FUNCTION IN HEART-FAILURE
    CLELAND, J
    GILLEN, G
    DARGIE, HJ
    ROBERTSON, JIS
    BRITISH HEART JOURNAL, 1985, 54 (06): : 655 - 656
  • [40] Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril
    Shu Kasama
    Takuji Toyama
    Hisao Kumakura
    Yoshiaki Takayama
    Shuichi Ichikawa
    Tadashi Suzuki
    Masahiko Kurabayashi
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 964 - 971
12345